−1.80SEK
−35.67 MSEK
5.54 MSEK
About COMBIGENE AB
Sector
CEO
Peter Ekolind
Headquarters
Lidingoe
Website
Employees (FY)
11
Founded
1990
ISIN
SE0016101935
FIGI
BBG008GSRXC8
CombiGene AB engages in the development of new treatment for neurological diseases. It focuses on the research of therapy for patients with epilepsy. The company was founded by Lars Thunberg, Merab Kokaia and David Woldbye in 1990 and is headquartered in Lidingoe, Sweden.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of COMBI is 3.85 SEK — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange COMBIGENE AB stocks are traded under the ticker COMBI.
Yes, you can track COMBIGENE AB financials in yearly and quarterly reports right on TradingView.
Like other stocks, COMBI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade COMBIGENE AB stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 16, 2024, the company has 11.00 employees. See our rating of the largest employees — is COMBIGENE AB on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. COMBIGENE AB EBITDA is −36.16 M SEK, and current EBITDA margin is −652.22%. See more stats in COMBIGENE AB financial statements.